General Information of Drug (ID: DMV8EXG)

Drug Name
PolyHeme
Synonyms Oxygen-carrying blood substitute, Northfield Laboratories
Indication
Disease Entry ICD 11 Status REF
Blood forming organ disorder JB64.1 Phase 3 [1]
Structure
3D MOL is unavailable 2D MOL
#Ro5 Violations (Lipinski):
0
Molecular Weight 347.26
Logarithm of the Partition Coefficient Not Available
Rotatable Bond Count 8
Hydrogen Bond Donor Count 3
Hydrogen Bond Acceptor Count 9
Chemical Identifiers
Formula
C13H18NO8P
IUPAC Name
(4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl dihydrogen phosphate;pentanedial
Canonical SMILES
CC1=NC=C(C(=C1O)C=O)COP(=O)(O)O.C(CC=O)CC=O
InChI
InChI=1S/C8H10NO6P.C5H8O2/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14;6-4-2-1-3-5-7/h2-3,11H,4H2,1H3,(H2,12,13,14);4-5H,1-3H2
InChIKey
SKKYPUWZZNPUMG-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
72941846
TTD ID
D00IWL

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Hemoglobin (HB) TTQO71U HBA_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT00076648) Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting. U.S. National Institutes of Health.
2 Blood substitutes- the polyheme trials. Mcgill J Med. 2008 January; 11(1): 59-65.